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Patient Alert and Cardiac Defibrillators
Becker et al. (1) recently analyzed the utility of patient-alert
features in implantable cardioverter-defibrillators (ICDs). Most
modern ICD devices monitor certain parts of the defibrillation
system, including lead impedance and battery status, continuously.
In case of adverse incidents (e.g., unexpected decrease or increase
in lead impedance, premature battery depletion) the device pro-
duces acoustic warning signals, and the system needs to be checked
by the doctor. The researchers concluded that such patient-alert
features are useful additional tools facilitating early detection of
serious ICD complications, but they may have low sensitivity.
We wish to report a case to illustrate that such patient-alert
features may confuse both the patient and the physician. A
62-year-old man was referred to an otorhinolaryngologist because
of a four-day history of recurrent short episodes of tinnitus. He had
a history of anterior myocardial infarction nine years ago. Subse-
quently, echocardiography revealed severe left ventricular dysfunc-
tion. The patient underwent implantation of a defibrillator because
of recurrent ventricular tachycardia four months ago. Otolaryngo-
logic examination was normal. When the patient thoroughly
described his medical history and his perception of the recurrent
ringing sound in his ears and head, the otolaryngologist considered
the presence of an external sound. Although, the otolaryngologist
was not aware of the monitor systems within ICDs that sound in
case of adverse incidents, he referred the patient to the cardiologist
to check the defibrillator. Evaluation of the defibrillator by
telemetry revealed unexpected increase in lead impedance requir-
ing immediate surgical revision (2).
Because ICDs have been clearly documented to revert sustained
ventricular tachyarrhythmias, including pace termination of sus-
tained ventricular tachycardia and shock reversion of ventricular
fibrillation, the number of patients treated with such devices for
secondary and primary prevention increases rapidly. Thus, ICD
patients should be informed in detail about the various features and
tools of their device including patient-alert systems. Additionally,
both training and education for ICDs are required not only for
cardiologists and general practitioners but for other professionals
within the medical community.
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REPLY
In their Letter to the Editor, Auer and colleagues reported the case
of an implantable cardioverter-defibrillator (ICD) patient with
suspected tinnitus who presented to an ear-nose-throat (ENT)
specialist. Although unaware of the patient-alert feature, the ENT
doctor suspected an external sound rather than tinnitus and
referred the patient to the cardiologist, who checked the patient’s
defibrillator and found that an increase in lead impedance had
triggered the patient-alert function. The impedance rise obviously
reflected severe lead dysfunction requiring immediate surgical
revision. The investigators conclude that training and education
about various ICD features including patient alert should be
provided to both patients and physicians. We believe that educat-
ing the entire medical community to various ICD features is hardly
feasible, but undoubtedly it makes no sense to activate features
such as patient alert without educating the patients. During
routine postimplant ICD programming, the alert signal should be
demonstrated to the patient (as available via programmer teleme-
try) and the alert time should be discussed and individually adapted
to the patient’s waking hours. If this becomes part of the clinical
routine, as in our center, the patient-alert feature may well be a
useful additional tool that facilitates early detection of system-
related complications (1). Moreover, even in the case presented by
Auer and colleagues, the alert feature served to disclose a severe
lead complication that otherwise would have been diagnosed only
at the next routine follow-up visit.
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